Regenerative Medical Technology Group Inc. Deferred Revenue, Revenue Recognized
Regenerative Medical Technology Group Inc. (RMTG) reported Deferred Revenue, Revenue Recognized of $1.53 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-14.
Discontinued › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2023-04-14
- Regenerative Medical Technology Group Inc. deferred revenue, revenue recognized for the quarter ending 2022-03-31 was $310.08K.
- Regenerative Medical Technology Group Inc. deferred revenue, revenue recognized for fiscal 2022 was $1.53M, a 221.98% increase from fiscal 2021.
- Regenerative Medical Technology Group Inc. deferred revenue, revenue recognized for fiscal 2021 was $475.26K.
| Period end | Deferred Revenue, Revenue Recognized 3 month | Deferred Revenue, Revenue Recognized 6 month | Deferred Revenue, Revenue Recognized 9 month | Deferred Revenue, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2022-12-31 | $1.53M 10-K · filed 2023-04-14 | |||
| 2022-09-30 | $988.96K 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | $614.60K 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | $310.08K 10-Q · filed 2022-05-19 | |||
| 2021-12-31 | $475.26K 10-K · filed 2022-05-05 |